ZA956986B - Methods of inhibiting viral replication. - Google Patents
Methods of inhibiting viral replication.Info
- Publication number
- ZA956986B ZA956986B ZA9506986A ZA956986A ZA956986B ZA 956986 B ZA956986 B ZA 956986B ZA 9506986 A ZA9506986 A ZA 9506986A ZA 956986 A ZA956986 A ZA 956986A ZA 956986 B ZA956986 B ZA 956986B
- Authority
- ZA
- South Africa
- Prior art keywords
- viral replication
- inhibiting viral
- methods
- image
- hexamethyleneamino
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
- A61K31/381—Heterocyclic compounds having sulfur as a ring hetero atom having five-membered rings
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Hydrogenated Pyridines (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US08/294,171 US5494920A (en) | 1994-08-22 | 1994-08-22 | Methods of inhibiting viral replication |
Publications (1)
Publication Number | Publication Date |
---|---|
ZA956986B true ZA956986B (en) | 1997-02-21 |
Family
ID=23132219
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZA9506986A ZA956986B (en) | 1994-08-22 | 1995-08-21 | Methods of inhibiting viral replication. |
Country Status (15)
Country | Link |
---|---|
US (1) | US5494920A (xx) |
EP (1) | EP0771200B1 (xx) |
JP (1) | JPH10504572A (xx) |
AT (1) | ATE189601T1 (xx) |
AU (1) | AU3408795A (xx) |
CA (1) | CA2198122A1 (xx) |
DE (1) | DE69515038T2 (xx) |
DK (1) | DK0771200T3 (xx) |
ES (1) | ES2141957T3 (xx) |
GR (1) | GR3033269T3 (xx) |
IL (1) | IL115014A0 (xx) |
MX (1) | MX9701329A (xx) |
PT (1) | PT771200E (xx) |
WO (1) | WO1996005830A1 (xx) |
ZA (1) | ZA956986B (xx) |
Families Citing this family (24)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6242199B1 (en) | 1995-12-13 | 2001-06-05 | Merck & Co., Inc. | Assays for growth hormone secretagogue receptors |
US6531314B1 (en) | 1996-12-10 | 2003-03-11 | Merck & Co., Inc. | Growth hormone secretagogue receptor family |
US6458811B1 (en) * | 1996-03-26 | 2002-10-01 | Eli Lilly And Company | Benzothiophenes formulations containing same and methods |
EP0910369B1 (en) * | 1996-03-26 | 2010-04-21 | Eli Lilly And Company | Benzothiophenes, formulations containing same, and methods |
ATE301129T1 (de) | 1999-05-04 | 2005-08-15 | Strakan Int Ltd | Androgen glykoside und die androgenische aktivität davon |
UA87854C2 (xx) | 2004-06-07 | 2009-08-25 | Мерк Энд Ко., Инк. | N-(2-бензил)-2-фенілбутанаміди як модулятори рецептора андрогену$n-(2-бензил)-2-фенилбутанамиды как модуляторы рецептора андрогена |
EP1819827B1 (en) * | 2004-12-08 | 2010-08-11 | Cedars-Sinai Medical Center | Methods for diagnosis of crohn's disease |
US20100021917A1 (en) * | 2007-02-14 | 2010-01-28 | Cedars-Sinai Medical Center | Methods of using genes and genetic variants to predict or diagnose inflammatory bowel disease |
US20100190162A1 (en) * | 2007-02-26 | 2010-07-29 | Cedars-Sinai Medical Center | Methods of using single nucleotide polymorphisms in the tl1a gene to predict or diagnose inflammatory bowel disease |
US20100015156A1 (en) * | 2007-03-06 | 2010-01-21 | Cedars-Sinai Medical Center | Diagnosis of inflammatory bowel disease in children |
WO2008116150A2 (en) | 2007-03-21 | 2008-09-25 | Cedars-Sinai Medical Center | Ileal pouch-anal anastomosis (ipaa) factors in the treatment of inflammatory bowel disease |
WO2008134569A2 (en) * | 2007-04-26 | 2008-11-06 | Cedars-Sinai Medical Center | Diagnosis and treatment of inflammatory bowel disease in the puerto rican population |
EP2155769B1 (en) * | 2007-05-04 | 2012-06-27 | Katholieke Universiteit Leuven KU Leuven Research & Development | Tissue degeneration protection |
US20100144903A1 (en) * | 2007-05-04 | 2010-06-10 | Cedars-Sinai Medical Center | Methods of diagnosis and treatment of crohn's disease |
US20110177969A1 (en) * | 2008-10-01 | 2011-07-21 | Cedars-Sinai Medical Center | The role of il17rd and the il23-1l17 pathway in crohn's disease |
US20110189685A1 (en) * | 2008-10-22 | 2011-08-04 | Cedars-Sinai Medical Center | Methods of using jak3 genetic variants to diagnose and predict crohn's disease |
WO2010062960A2 (en) | 2008-11-26 | 2010-06-03 | Cedars-Sinai Medical Center | METHODS OF DETERMINING RESPONSIVENESS TO ANTI-TNFα THERAPY IN INFLAMMATORY BOWEL DISEASE |
US9580752B2 (en) | 2008-12-24 | 2017-02-28 | Cedars-Sinai Medical Center | Methods of predicting medically refractive ulcerative colitis (MR-UC) requiring colectomy |
WO2013190520A2 (en) | 2012-06-22 | 2013-12-27 | The General Hospital Corporation | Gh-releasing agents in the treatment of vascular stenosis and associated conditions |
BR112015024752A2 (pt) | 2013-03-27 | 2017-07-18 | Cedars Sinai Medical Center | mitigação e reversão da fibrose e inflamação através da inibição da função de tl1a e vias de sinalização relacionadas |
WO2015010108A1 (en) | 2013-07-19 | 2015-01-22 | Cedars-Sinai Medical Center | Signature of tl1a (tnfsf15) signaling pathway |
EP3148587B1 (en) | 2014-05-30 | 2021-02-24 | Pfizer Inc | Carbonitrile derivatives as selective androgen receptor modulators |
US11186872B2 (en) | 2016-03-17 | 2021-11-30 | Cedars-Sinai Medical Center | Methods of diagnosing inflammatory bowel disease through RNASET2 |
WO2023275715A1 (en) | 2021-06-30 | 2023-01-05 | Pfizer Inc. | Metabolites of selective androgen receptor modulators |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4133814A (en) * | 1975-10-28 | 1979-01-09 | Eli Lilly And Company | 2-Phenyl-3-aroylbenzothiophenes useful as antifertility agents |
US4418068A (en) * | 1981-04-03 | 1983-11-29 | Eli Lilly And Company | Antiestrogenic and antiandrugenic benzothiophenes |
US4380635A (en) * | 1981-04-03 | 1983-04-19 | Eli Lilly And Company | Synthesis of acylated benzothiophenes |
US5395842A (en) * | 1988-10-31 | 1995-03-07 | Endorecherche Inc. | Anti-estrogenic compounds and compositions |
JP3157882B2 (ja) * | 1991-11-15 | 2001-04-16 | 帝国臓器製薬株式会社 | 新規なベンゾチオフエン誘導体 |
-
1994
- 1994-08-22 US US08/294,171 patent/US5494920A/en not_active Expired - Fee Related
-
1995
- 1995-08-21 AT AT95930863T patent/ATE189601T1/de not_active IP Right Cessation
- 1995-08-21 CA CA002198122A patent/CA2198122A1/en not_active Abandoned
- 1995-08-21 EP EP95930863A patent/EP0771200B1/en not_active Expired - Lifetime
- 1995-08-21 IL IL11501495A patent/IL115014A0/xx unknown
- 1995-08-21 JP JP8508230A patent/JPH10504572A/ja not_active Withdrawn
- 1995-08-21 PT PT95930863T patent/PT771200E/pt unknown
- 1995-08-21 DK DK95930863T patent/DK0771200T3/da active
- 1995-08-21 DE DE69515038T patent/DE69515038T2/de not_active Expired - Fee Related
- 1995-08-21 MX MX9701329A patent/MX9701329A/es unknown
- 1995-08-21 ES ES95930863T patent/ES2141957T3/es not_active Expired - Lifetime
- 1995-08-21 WO PCT/US1995/010580 patent/WO1996005830A1/en active IP Right Grant
- 1995-08-21 ZA ZA9506986A patent/ZA956986B/xx unknown
- 1995-08-21 AU AU34087/95A patent/AU3408795A/en not_active Abandoned
-
2000
- 2000-04-19 GR GR20000400952T patent/GR3033269T3/el not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
MX9701329A (es) | 1997-05-31 |
EP0771200B1 (en) | 2000-02-09 |
DE69515038D1 (de) | 2000-03-16 |
WO1996005830A1 (en) | 1996-02-29 |
ATE189601T1 (de) | 2000-02-15 |
CA2198122A1 (en) | 1996-02-29 |
EP0771200A1 (en) | 1997-05-07 |
US5494920A (en) | 1996-02-27 |
IL115014A0 (en) | 1995-12-08 |
DK0771200T3 (da) | 2000-05-15 |
EP0771200A4 (en) | 1997-09-10 |
GR3033269T3 (en) | 2000-09-29 |
ES2141957T3 (es) | 2000-04-01 |
PT771200E (pt) | 2000-07-31 |
AU3408795A (en) | 1996-03-14 |
JPH10504572A (ja) | 1998-05-06 |
DE69515038T2 (de) | 2000-06-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GR3033269T3 (en) | Methods of inhibiting viral replication | |
MX9701360A (es) | Metodos para la inhibicion de la desmielinizacion y las enfermedades de la dismielinizacion. | |
MX9701325A (es) | Metodos para inhibir la mucositis ulcerativa. | |
MX9701334A (es) | Metodos para inhibir la degeneracion de protesis oseas. | |
MX9709466A (es) | Medicamento para inhibir el melanoma. | |
MX9701333A (es) | Metodos para inhibir el daño neuronal. | |
MX9702148A (es) | Metodos para inhibir la mitosis endometrial. | |
MX9701327A (es) | Metodos para inhibir el cancer endometrial. | |
IL115016A0 (en) | Methods for bone healing and fracture repair | |
MX9701359A (es) | Metodos para la inhibicion de la hiperplasia endometrial primaria. | |
MX9701331A (es) | Metodos para mantener los dientes y los huesos bucales. | |
MX9709536A (es) | Metodo para reducir el factor de transcripcion bef-1. | |
MX9709651A (es) | Metodos para modulacion del factor de transcripcion nf-kb. | |
MX9705940A (es) | Metodos y composiciones para inhibir los efectos de la interleucina 6. | |
MX9705215A (es) | Uso de 2-fenil-3-aroilbenzotiofenos para inhibir los efectos de la hormona del crecimiento. | |
IL115023A0 (en) | Methods of reducing scarring in wound healing | |
MX9705537A (es) | Metodos y composiciones para inhibir el efecto de los estrogenos del medio ambiente. | |
MX9706072A (es) | Metodos de inhibicion de la adhesion celula-celula. | |
MX9706520A (es) | Metodos para inhibir el cancer de ovario. | |
MX9702861A (es) | Metodo para inhibir las condiciones asociadas con la bradicinina. | |
MX9702853A (es) | Metodos para inhibir condiciones asociadas con el neuropeptido "y". | |
MX9705697A (es) | Metodos para reducir los niveles de calcio del suero. |